(Q54630883)
Statements
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab. (English)
Xabier Garcia-Albeniz
Virginia Alonso-Espinaco
Vicente Alonso
Pilar Escudero
Carlos Fernández-Martos
Rosa Gallego
Pere Gascón
Sergi Castellví-Bel
Joan Maurel
23 November 2010
32
2
417-424
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference